Accordingly, inhibiting menin in ER-positive luminal breast cancer cell lines reduced cell growth [267,269,270], suggesting that menin promotes breast cancer progression by augmenting oncogenic ERα target gene expression downstream of estrogen signaling. The gene discussed is ESR1; the disease is breast carcinoma.